Perceptive

CROs/Service Providers

Charles River, CHDI Foundation extend Huntington's disease collaboration

Monday, November 10, 2014 12:18 PM

CRO Charles River International, based in Wilmington, Mass., and the CHDI Foundation, a U.S., privately-funded, nonprofit, biomedical research organization, have extended an ongoing collaboration for an additional five years through 2019. The collaboration, which began in 2005, is focused on discovering novel drugs for Huntington's disease.

More... »


GVK BIO to acquire Vanta Bioscience

Friday, November 7, 2014 01:09 PM

GVK BIO, a Hyderabad, India-based discovery R&D organization, will acquire Vanta Bioscience, a full-service preclinical GLP toxicology and safety assessment CRO operating from Chennai, India.

More... »

Quest Diagnostics

FDA selects Icon to work on PRO measures for pneumonia trials

Thursday, November 6, 2014 12:38 PM

Global CRO Icon, based in Dublin, has been awarded a project by the FDA to develop an industry-standard Patient Reported Outcome (PRO) measure that can be used in anti-bacterial drug development trials for hospital-acquired bacterial pneumonia (HABP). 

More... »

ERT acquires eClinical Insights

Thursday, November 6, 2014 12:36 PM

ERT, a Philadelphia, Pa.-based global solution provider for high-quality patient safety and efficacy endpoint data collection, has acquired eClinical Insights (eCI), a Cambridge, Mass.-based provider of cloud-based clinical trials management software.

More... »

DaVita Clinical Research, St. Anthony Hospital collaborate

Wednesday, November 5, 2014 01:57 PM

DaVita Clinical Research (DCR), a Minneapolis, Minn.-based specialty CRO, now can offer its sponsors increased patient access, on-site ancillary services and specialty physician experience in key therapeutic areas through a partnership with St. Anthony Hospital in Lakewood, Colo. 

More... »

Chiltern launches rebranding

Monday, November 3, 2014 02:37 PM

U.K.-based Chiltern has rebranded as a completely integrated and unified CRO with services that are "Designed Around You.”

More... »

Celerion expands lab capabilities for cell-based assay demand

Monday, November 3, 2014 02:36 PM

Celerion, a Lincoln, Neb.-based provider of early clinical research, has expanded laboratory capabilities to meet growing demand for cell-based assays. Assays involving whole cells provide a variety of measures of drug activity or effect that can be important endpoints in clinical research.

More... »

Clinical Network Services partners with Biologics Development Consultancy

Monday, November 3, 2014 02:34 PM

Clinical Network Services (CNS), an Australian, New Zealand and U.K. CRO focused on virtual, small and medium-sized biotech companies, and Biologics Development Consultancy (BDC), a Netherlands-based team of consultants providing regulatory and product development advice on development and commercial production, have signed a cooperative partnership agreement. CNS, and in particular the BioDesk consultancy, and BDC will mutually expand the expertise they can offer their clients.

More... »

LabCorp to acquire Covance, creating giant one-stop shop for diagnostics, clinical research

Monday, November 3, 2014 12:57 PM

By Ronald Rosenberg
CenterWatch Staff Writer

Laboratory Corp. of America Holdings (LabCorp), a large provider of medical testing services, has agreed to acquire CRO Covance in a $6.1 billion cash and stock deal to create a giant healthcare diagnostics company.      

More... »

Charles River acquires ChanTest

Thursday, October 30, 2014 12:24 PM

Massachusetts-based CRO Charles River Laboratories International has acquired Cleveland-based ChanTest, a provider of specialized laboratory testing services for drug development, from Wellesley, Mass.-based Ampersand Capital Partners, in an all-cash transaction.

More... »

CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs